Multiple studies have found poor survival for BRCA2 carriers compared with noncarriers28,29,61,70–72BRCA2 carriers have a stronger association with Gleason score ≥ 7 cancer than with Gleason score ≤ 6, cancer and a higher risk of death from prostate cancer66. The gene discussed is BRCA2; the disease is cancer.